Wednesday, January 20, 2016
OncoGenex Announces Update on Phase 2 Spruce Trial in Previously Untreated Metastatic Non-Small Cell Lung Cancer
… of lung cancer patients," said principal investigator David Spigel, director, lung cancer research … including exciting immunotherapies, patients with lung cancer still have a significant need … with advanced, unresectable non-small cell lung cancer. Apatorsen is in Phase 2 …
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment